Sherlock gets $7.5M to create COVID-19 diagnostics

By staff writers

May 21, 2020 -- Open Philanthropy has advanced $7.5 million in grant funding to engineering biology company Sherlock Biosciences for diagnostics related to the novel coronavirus.

The nondilutive grant funding will help Sherlock further advance its CRISPR gene-editing technology platform, which it used to create its Sherlock CRISPR SARS-CoV-2 detection kit. The funding will also support the development of the company's Inspectr platform, which powers its COVID-19 diagnostic.

Sherlock is currently looking to hire 10 to 15 molecular diagnostic experts to help advance its Inspectr-based COVID-19 solution. The Inspectr platform aims to conduct instrument-free, handheld diagnostic tests that work similarly to an at-home pregnancy test.

Sherlock's novel CRISPR coronavirus test cleared in U.S.
Engineering biology company Sherlock Biosciences has received emergency use authorization from the U.S. Food and Drug Administration for a detection kit...
Could mPOC come to the rescue in COVID-19 outbreak?
Molecular point-of-care (mPOC) systems are poised to play an important role in the novel coronavirus outbreak, writes Bruce Carlson, publisher of market...
CRISPR proteins lead to novel POC diagnostics
A novel tool that detects the presence of specific nucleic acid sequences is the basis for a new family of point-of-care (POC) diagnostics, which could...

Copyright © 2020

Last Updated ls 5/21/2020 3:11:33 PM

Register below for our weekly Letter from the Editor to receive the latest Clinical Lab news and insights.
Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current